SG2000 has significant in vivo antitumour activity against canine melanoma tumour xenografts, and the comet and γ-H2AX foci methods are shown to be relevant in vivo pharmacodynamic assays for measuring DNA ICL and DNA damage response. This evidence concerns the gene H2AX and neoplasm.